(Q47634491)

English

Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of acute treatment outcomes in clinical practice

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/22689344

Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of acute treatment outcomes in clinical practice (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/22689344

author name string

Linda L Carpenter

1

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/22689344

Philip G Janicak

2

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/22689344

Scott T Aaronson

3

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/22689344

Terrence Boyadjis

4

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/22689344

David G Brock

5

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/22689344

Ian A Cook

6

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/22689344

David L Dunner

7

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/22689344

Karl Lanocha

8

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/22689344

H Brent Solvason

9

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/22689344

Mark A Demitrack

10

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/22689344

publication date

11 June 2012

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/22689344

Depression and Anxiety

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/22689344

29

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/22689344

7

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/22689344

587-596

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/22689344

The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R)

1 reference

https://api.crossref.org/works/10.1002%2FDA.21969

21 January 2018

Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report

1 reference

https://api.crossref.org/works/10.1002%2FDA.21969

21 January 2018

Cognitive effects of high-frequency repetitive transcranial magnetic stimulation: a systematic review

1 reference

https://api.crossref.org/works/10.1002%2FDA.21969

21 January 2018

Efficacy of repetitive transcranial magnetic stimulation in depression: a review of the evidence

1 reference

https://api.crossref.org/works/10.1002%2FDA.21969

21 January 2018

Transcranial magnetic stimulation in the management of mood disorders.

1 reference

https://api.crossref.org/works/10.1002%2FDA.21969

21 January 2018

Has repetitive transcranial magnetic stimulation (rTMS) treatment for depression improved? A systematic review and meta-analysis comparing the recent vs. the earlier rTMS studies

1 reference

https://api.crossref.org/works/10.1002%2FDA.21969

21 January 2018

Repetitive transcranial magnetic stimulation for treatment-resistant depression: a systematic review and metaanalysis

1 reference

https://api.crossref.org/works/10.1002%2FDA.21969

21 January 2018

A review of the efficacy of transcranial magnetic stimulation (TMS) treatment for depression, and current and future strategies to optimize efficacy

1 reference

https://api.crossref.org/works/10.1002%2FDA.21969

21 January 2018

Transcranial magnetic stimulation for depression and other psychiatric disorders.

1 reference

https://api.crossref.org/works/10.1002%2FDA.21969

21 January 2018

Antidepressant efficacy of high-frequency transcranial magnetic stimulation over the left dorsolateral prefrontal cortex in double-blind sham-controlled designs: a meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FDA.21969

21 January 2018

Should we expand the toolbox of psychiatric treatment methods to include Repetitive Transcranial Magnetic Stimulation (rTMS)? A meta-analysis of the efficacy of rTMS in psychiatric disorders.

1 reference

https://api.crossref.org/works/10.1002%2FDA.21969

21 January 2018

Selecting among second-step antidepressant medication monotherapies: predictive value of clinical, demographic, or first-step treatment features

1 reference

https://api.crossref.org/works/10.1002%2FDA.21969

21 January 2018

Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FDA.21969

21 January 2018

Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial

1 reference

https://api.crossref.org/works/10.1002%2FDA.21969

21 January 2018

Improving the antidepressant efficacy of transcranial magnetic stimulation: maximizing the number of stimulations and treatment location in treatment-resistant depression

1 reference

https://api.crossref.org/works/10.1002%2FDA.21969

21 January 2018

Can phase III trial results of antidepressant medications be generalized to clinical practice? A STAR*D report

1 reference

https://api.crossref.org/works/10.1002%2FDA.21969

21 January 2018

Safety, tolerability, and effectiveness of high doses of adjunctive daily left prefrontal repetitive transcranial magnetic stimulation for treatment-resistant depression in a clinical setting.

1 reference

https://api.crossref.org/works/10.1002%2FDA.21969

21 January 2018

Accelerated repetitive transcranial magnetic stimulation for treatment-resistant depression

1 reference

https://api.crossref.org/works/10.1002%2FDA.21969

21 January 2018

Transcranial magnetic stimulation in the treatment of major depressive disorder: a comprehensive summary of safety experience from acute exposure, extended exposure, and during reintroduction treatment.

1 reference

https://api.crossref.org/works/10.1002%2FDA.21969

7 January 2021

based on heuristic

inferred from DOI database lookup

Neuropsychiatric applications of transcranial magnetic stimulation: a meta analysis.

1 reference

https://api.crossref.org/works/10.1002%2FDA.21969

7 January 2021

based on heuristic

inferred from DOI database lookup

Factors modifying the efficacy of transcranial magnetic stimulation in the treatment of depression: a review.

1 reference

https://api.crossref.org/works/10.1002%2FDA.21969

7 January 2021

based on heuristic

inferred from DOI database lookup

Meta-analysis of left prefrontal repetitive transcranial magnetic stimulation (rTMS) to treat depression.

1 reference

https://api.crossref.org/works/10.1002%2FDA.21969

7 January 2021

based on heuristic

inferred from DOI database lookup

What is the threshold for symptomatic response and remission for major depressive disorder, panic disorder, social anxiety disorder, and generalized anxiety disorder?

1 reference

https://api.crossref.org/works/10.1002%2FDA.21969

7 January 2021

based on heuristic

inferred from DOI database lookup

Personality and clinical predictors of recurrence of depression

1 reference

https://api.crossref.org/works/10.1002%2FDA.21969

7 January 2021

based on heuristic

inferred from DOI database lookup

A Randomized, Controlled Trial of Sequential Bilateral Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Depression

1 reference

https://api.crossref.org/works/10.1002%2FDA.21969

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/DA.21969

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/22689344

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/22689344

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47634491&oldid=2163371939"